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ABSTRACT
The relative levels of different p factors dictate the
expression profile of a bacterium. Extracytoplasmic
function p factors synchronize the transcriptional
profile with environmental conditions. The cellular
concentration of free extracytoplasmic function p
factors is regulated by the localization of this
protein in a p/anti-p complex. Anti-p factors are
multi-domain proteins with a receptor to sense en-
vironmental stimuli and a conserved anti-p domain
(ASD) that binds a p factor. Here we describe the
structure of Mycobacterium tuberculosis anti-pD
(RsdA) in complex with the -35 promoter binding
domain of pD (pD4). We note distinct conformational
features that enable the release of pD by the select-
ive proteolysis of the ASD in RsdA. The structural
and biochemical features of the pD/RsdA complex
provide a basis to reconcile diverse regulatory
mechanisms that govern p/anti-p interactions
despite high overall structural similarity. Multiple
regulatory mechanisms embedded in an ASD
scaffold thus provide an elegant route to rapidly
re-engineer the expression profile of a bacterium
in response to an environmental stimulus.
INTRODUCTION
The ability of Mycobacterium tuberculosis to persist in the
host for extended periods of time suggests an efficient
intracellular response to environmental stimuli. A class
of transcription factors, the extracytoplasmic function s
factors (ECF), exclusively synchronize changes in the tran-
scription profile with environmental conditions. M. tuber-
culosis has 13 s factors of which 10 belong to the ECF
family. These s factors play an important role in the
complex life cycle of M. tuberculosis (1,2). A majority of
ECF s factors are localized in an inactive complex by
their association with anti-s factors. The anti-s factor
could either be cytosolic (for example, RsbW and
Rv1222 in M. tuberculosis) or membrane associated
(M. tuberculosis RsdA, RskA and RslA). The cellular con-
centration of free ECF s factors is regulated by the release
of this protein from an inhibited s/anti-s factor complex.
Multiple mechanistic routes have been demonstrated to
regulate the release of a s factor from a s/anti-s factor
complex. The regulation of s factor activity by a proteo-
lytic cascade is best examined in the case of the Escherichia
coli ECF, sE. RseA, the anti-s factor for sE, is a receptor
protein. RseA is proteolyzed by a two-step mechanism,
and the proteolytic action of DegS triggers the activity
of a membrane-embedded protease RseP. This results in
the release of the cytosolic segment of RseA bound to sE.
The anti-s domain (ASD) of RseA is subsequently
degraded by the ClpX–ClpP proteolytic complex.
Caseinolytic protease (Clp) proteases degrade aggregated
and denatured proteins or nascent proteins formed due to
stalled ribosomes (3,4). Of the two components in the pro-
teolytic complex, the protease subunit (ClpP) forms a
pore-like structure that helps in the cleavage of the
unfolded polypeptide. Two heptameric rings of ClpP
interact with one hexameric ring of either ClpX or ClpA
(5). The motor proteases (ClpX or ClpA) interact at either
one or both ends of the ClpP pore. This assembly forms a
hollow cylinder containing protease subunits capped at
both ends by motor subunits that interact with the
heptameric ring of ClpP (6). This arrangement (ClpX–
ClpP or ClpA–ClpP complex) is similar to the eukaryotic
proteasome, which has a central proteolytic cavity capped
at both ends by ATPases (7). The choreographed action of
membrane and cytosolic proteases is brought about by the
exposure of a sequence motif in the ASD, and in this case,
a ‘VAA’ motif at the C-terminus of cytosolic RseA (8,9).
This regulatory mechanism has also been demonstrated
for the Bacillus subtilis sW/RsiW and the Pseudomonas
aeruginosa AlgU/MucA complexes (10–12). The existence
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of a similar proteolytic cascade in M. tuberculosis
was demonstrated recently (13,14). M. tuberculosis Rip1
was identified as a site-2 protease for three membrane-
associated anti-s factors RskA, RslA and RsmA.
M. tuberculosis RsdA was not affected by Rip1 activity
(15). Conformational change triggered by environmental
stimuli can also result in the release of a s factor from a
s/anti-s factor complex. In the case of M. tuberculosis
sL/RslA, for example, conformational change on
Zn2+ release governs the dissociation of the sL/RslA
complex (16).
M. tuberculosis has only one ribosomal RNA operon—
efficient transcription of this operon is thus a prerequisite
for the survival of the bacillus. The sD regulates the ex-
pression of the ribosomal RNA operon. The sD deletion
mutant (M. tuberculosis sigD) was found to have lower
expression levels of genes encoding constituents of the
ribosome, elongation factors, DNA-binding proteins and
enzymes involved in adenosine triphosphate (ATP) bio-
synthesis (17). Although the sigD mutant showed per-
sistence and colony-forming units similar to the wild type
strain of M. tuberculosis, the time to death was signifi-
cantly delayed (2,17). These studies suggested that sD
maintains homeostasis in the late stationary phase of
M. tuberculosis growth. Furthermore, similar to the rel
deletion mutant in M. tuberculosis, it was noted that
the so-called PE-PGRS proteins are up-regulated in the
sigD mutant. These proteins are recognized by the
immune system (18). The expression level of sigD is
up-regulated in response to starvation, down-regulated
during macrophage infection and hypoxia while being
relatively stable in the exponential phase and stationary
growth conditions (2). The sD is also involved in the regu-
lation of the resuscitation-promoting factor, a protein that
plays a crucial role in the renewal of bacterial growth after
starvation or stationary phase (18).
Here we describe the crystal structure of the ASD of
RsdA in complex with the -35 promoter element recogni-
tion domain of sD (sD4). Sequence analysis suggested
the presence of a C-terminal ClpX recognition motif in
the trans-membrane region of two M. tuberculosis anti-s
factors RsdA and RslA. We note that while the M. tuber-
culosis ClpX–ClpP1–ClpP2 proteolytic complex could
specifically degrade the ASD of RsdA, the ASD of RslA
was resistant to proteolysis. This observation suggests
that sequence features alone are insufficient to trigger the
proteolytic degradation of an ASD. The influence of con-
formational variations in the ASD in selective proteolytic
regulation was examined by Molecular Dynamics (MD)
simulations. MD simulations allow atoms and molecules
to interact at a fixed temperature for a period of time.
These interactions, which follow the laws of classical mech-
anics, provide information on atomic motion that can po-
tentially rationalize biological mechanisms. MD
simulations suggest that RsdA is more flexible than
RslA. It thus appears likely that despite having a recogni-
tion sequence for proteolytic degradation, the release of sL
from the sL/RslA complex is regulated by conformational
changes in RslA triggered by the release of a Zn2+cofactor
(16). The structurally conserved ASD thus appears to
encode distinct regulatory mechanisms providing an
elegant route to synchronize intracellular s-factor levels
with an environmental stimulus.
MATERIALS AND METHODS
Expression and purification of recombinant proteins
The details of the expression constructs used to obtain
recombinant sD, RsdA (Rv3413c), ClpX, ClpP1 and
ClpP2 are summarized in Supplementary Table S1. A
single primer-based approach was used to obtain point
variants of RsdA (19). sD/RsdA and sD4/RsdA were
purified by a co-expression and co-purification strategy.
All the proteins used in the proteolysis assays as well as
crystallization trials were purified using the same protocol
unless otherwise mentioned. In each case, the plasmid
encoding the gene of interest was transformed into
E. coli BL21(DE3). Transformed colonies were grown in
Luria broth with appropriate antibiotic markers till the
cell density reached an O.D.600 of 0.5–0.6. Cells were
induced with 0.3mM Isopropyl b-D-1-thiogalactopy-
ranoside, and post-induction, the temperature was
reduced to 18C for 12–13 h. Thereafter, these cells were
harvested at 6000 rpm followed by re-suspension and
sonication in lysis buffer (50mM Tris–HCl, pH 7.5 and
300mM NaCl). The lysate was centrifuged at 15 000 rpm
and subsequently incubated with Ni2+-Nickel-nitrilo
triacetic acid (NTA) affinity beads (Sigma-Aldrich, Inc.)
for 1 h at 4C. The bound protein was eluted by a gradient
of imidazole concentration (5mM to 200mm). Further
purification was achieved by size exclusion chromatog-
raphy on a Sephacryl Hiprep 16/60 S-200 column
(Amersham Biosciences) in a buffer containing 50mM
Tris–HCl, pH 8.0, 300mM NaCl and 2% glycerol. The
molecular weights of purified proteins were verified by
liquid chromatography–electrospray ionization mass spec-
trometry (Bruker Daltonics, Inc.).
Crystallization and structure determination
Crystallization trials for sD4 and the s
D
4/RsdA complex
were performed using sparse matrix screens (Hampton
Research) with conditions being examined by both
hanging drop as well as under oil methods at room tem-
perature. The crystallization drops contained 2 ml of
protein (8mg/ml) and 2 ml of the crystallization condition.
Diffraction quality crystals of sD4 were obtained in a con-
dition containing 1.0–1.3M ammonium sulfate, 0.1M
Tris–HCl, 5% 2-methyl-2, 4-pentanediol, 3% glycerol,
pH 7.8 in 3–4 weeks. Diffraction quality crystals of sD4/
RsdA complex were obtained in a condition containing
1.0–1.5M ammonium sulfate, 0.1M 4-(2-hydroxyethyl)-
1-piperazineethanesulfonic acid (HEPES), 15–20%
polyethylene glycol (PEG) 4000, pH 7.4 within 3–4 days.
Crystals were flash frozen in liquid nitrogen using 7%
glycerol as cryo-protectant. Diffraction data were col-
lected at 0.978A˚ at the BM-14 beam-line of the
European Synchrotron Radiation Facility, Grenoble.
The data were integrated and scaled using iMOSFLM
and SCALA (20,21). The initial phases of sD4 were
obtained using Phenix (22) by the Single-wavelength
Anomalous Diffraction (SAD) method. The structure of
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the sD4/RsdA complex was solved by Molecular
Replacement–Single-wavelength Anomalous Diffraction
(MR-SAD) using the sD4 model. An initial model of the
complex was obtained using the Autobuild module of
Phenix. Subsequent model building and refinement was
performed using COOT (23) and Phenix. The fit of the
model to the electron density was evaluated by COOT.
It was important to use translation–libration–screw
(TLS) restraints obtained from the TLSMD server (24)
to achieve convergence in refinement.
Molecular dynamics simulations
MD simulations were performed using the GROMACS
v4.0.2 package with OPLS-AA/L force field (25,26).
During the simulations, crystallographic water molecules
were removed and the protein model was solvated with the
TIP4P water model. All simulations used the isothermal–
isobaric ensemble (constant pressure of 1 bar and tempera-
ture set to 300K). Energy minimizations were performed
using the conjugate gradient and steepest descent methods
with a frequency of the latter set to 1 in 1000. Simulations
were performed with full periodic boundary conditions.
Bonds were constrained with the LINear Constraint
Solver (LINCS) algorithm (27). The sD4, s
D
4/RsdA
complex, RsdA, sL4/RslA complex and RslA structural
models were subjected to MD simulations for 50 ns.
Structure analysis was performed by GROMACS tools
and local unix scripts. Graphical representations were
prepared using the Sigma-plot software (Systat
Software). Secondary structural elements were ascertained
using the Dictionary of Secondary Structure of Proteins
(DSSP) software (28). The protein–protein interaction
interface was analyzed using the Contact program from
the CCP4 suite, while the interaction networks were rep-
resented using cytoscape (21,29).
Protease assays
All protease assays were performed in a buffer containing
25mM HEPES–KOH (pH 7.5), 5mM KCl, 5mMMgCl2,
0.02% NP-40 and 10% glycerol at 37C (8). To monitor
the proteolysis of RsdA194 and RslA1125, Clp proteases
(ClpX: 0.3 mM, ClpP1, ClpP2 or ClpP1–ClpP2: 0.8 mM),
ATP (4mM) and an ATP-regeneration system (50 mg/ml
creatine kinase and 2.5mM creatine phosphate) were pre-
incubated and anti-s factor substrates [RsdA194,
sD/RsdA194, sL/RslA1125or RslA1125 (5.0–6.0 mM)]
were added. Samples were removed at different time inter-
vals, and a western blot was performed using anti-histidine
monoclonal antibodies (GE Healthcare) at 1:2000 dilution
for the detection of RsdA and RslA, while the s factors
were probed with anti-sD and anti-sL monoclonal
antibodies at 1:2000 dilution. Immunoblots were
developed with 3-amino-9-ethylcarbazole (Sigma-
Aldrich, Inc) and H2O2 for peroxidase-attached secondary
antibodies.
Surface plasmon resonance measurements
Interaction between sD and RsdA and sD4 and RsdA
were examined using surface plasmon resonance (SPR)
(BIACORE 3000; GE Healthcare). sD and sD4 were
immobilized on a CM5 chip (BIACORE; GE
Healthcare) at a surface density of 12 ng/mm2. RsdA
and the W50A mutant of RsdA were used as analytes in
this study. The interaction kinetics was evaluated using
BIAevaluation software. The first lane of the chip was
used as control and all the interactions were examined in
a buffer containing 20mM Tris–HCl and 300mM NaCl
(pH 7.8).
RESULTS AND DISCUSSION
Crystallization and structure determination of pD4 and the
pD4/RsdA complex
RsdA is the cognate anti-s factor for sD and full-length
sD interacts with the cytosolic component of RsdA (30).
Crystallization trials were performed to obtain crystals of
full-length sD and the ASD of RsdA (RsdA180). The
crystalline precipitates from these experiments, however,
could not be improved. Crystals appeared after a month;
these corresponded to sD4
141212 and RsdA. A recombin-
ant protein fragment based on this finding (sD4 and RsdA
co-expressed in E. coli) yielded crystals of the sD4/RsdA
complex within 2–3 days. In the subsequent description of
this complex, the sequence lengths of sD4 and RsdA cor-
respond to the protein construct in the sD4/RsdA complex
structure; variations in the sequence length used for bio-
chemical analysis are explicitly noted (Supplementary
Table S1). The data collection, refinement and model stat-
istics are presented in Table 1.
Structure of pD4 in the free and RsdA-bound form
The sD4 structure could be superposed on other s4 models
with a root-mean-square deviation (r.m.s.d.) of 1.2 A˚
(Figure 1a; Supplementary Figures S1a and b). The sD4
structures determined independently for the free form and
the sD4/RsdA complex are not substantially different
(r.m.s.d. of 0.7 A˚ between Ca atoms). The structural simi-
larity between the free and bound forms of sD4 suggests
that unlike the structure of the E. coli sA/AsiA complex
(33) where domain 4 ofs70 adopts a different conformation
in the anti-s bound form, the sD4 conformation is not
altered on binding RsdA. The stoichiometry observed in
the crystal structure of the sD4/RsdA complex is consistent
with solution studies, and both sD4/RsdA and s
D/RsdA
complexes adopt a 1:1 interaction stoichiometry in solution.
There are four molecules of the sD4/RsdA complex in
the asymmetric unit. In each protomer, RsdA adopts an
identical conformation with two helices connected by a
loop. The C-terminal helix could not be modeled due to
poor electron density. Helix H1 of RsdA interacts with
helices H1’ and H4’ of sD4, while helix H3 interacts
with H4’ of sD4 (Supplementary Figure S1). The buried
surface area in the sD4/RsdA complex is 1067.5A˚
2, com-
parable with other s4/ASD complexes (Supplementary
Table S2). A superposition of the sD4/RsdA complex on
the E. coli sE promoter DNA complex structure suggests
that sD is inactivated by the occlusion of -35 promoter
element binding region. The interaction between s4 and
the anti-s factor could potentially also facilitate regula-
tory mechanisms involving other proteins or small
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molecule effectors. These possibilities are best exemplified
in the case of the E. coli s704/Rsd complex. E. coli s
70
4
binds the b-flap tip of the RNA polymerase enzyme and is
a target for transcriptional activators in addition to its role
in -35 promoter element binding. Three exposed cavities
on distinct surfaces of Rsd in the E. coli s704/Rsd complex
could potentially rationalize small molecule effector
binding (34–36). A common theme that emerges from
these structures is that regulation of s-factor activity by
the anti-s factor involves occlusion of interacting surfaces
in s4 rather than conformational changes in the s4
domain.
The anti-sigma domain of RsdA
In all ASDs structurally characterized thus far, helices H1
and H3 are required for interaction with s4, while H2
helps in positioning helices H1 and H3 to interact with
the s factor. The fourth helix (H4) binds s2 (32). The
first three helices were noted to be well conserved across
all anti-s–factor structures. In the sD4/RsdA structure,
the ASD has only two helices; helix H2 is a loop in
RsdA, while H4 could not be modeled owing to poor
electron density (Figure 1a).
Although RsdA had a loop instead of helix H2, the
orientation of helices H1 and H3 is similar to other
ASDs. This is seen from the structural superposition of
helices H1, H2 and H3 of RslA (r.m.s.d. of 2.7 A˚ over 27
a-carbon positions), RseA (r.m.s.d. of 2.1 A˚ over 33 a-
carbons) and ChrR (r.m.s.d. of 2.0 A˚ over 34 a-carbons)
on RsdA (Figure 1d). Superposition of ASDs also
suggests that helix H3 is the most conserved secondary
structural element when compared with helices H1 and
H2. A sequence search revealed other ASDs similar to
RsdA. Protein sequences corresponding to genes that
have an ECF s factor in the same operon, share at least
30% identity and possess a trans-membrane segment were
considered as putative anti-s factors for this analysis.
Sequence-based secondary structure prediction performed
using PSIPRED (37) suggests three helices instead of
four—a finding consistent with the crystal structure of
RsdA (Figure 1c; Supplementary Figure S1c and Supple-
mentary Table S3). Another interesting observation from
the multiple sequence analysis (38) is that the cytosolic
ASDs of these trans-membrane proteins are better
conserved than their periplasmic domains.
The ASD is a common structural fold in ECF (also
referred to as group IV) anti-s factors. While the fold of
the ASD is conserved, the interactions between an ASD
and a cognate s factor show substantial variations. This
feature was noted from several characterized s4/ASD
complexes. Thus while the conformation of s4 is distorted
in both E. coli s70/AsiA and the Rhodobacter sphaeroides
sE/ChrR complexes, this is not the case in either E. coli
sE/RseA or the M. tuberculosis sL4/RslA or s
D
4/RsdA
complex. A comparison between the ChrR and RseA
ASDs suggested that while the secondary structural
content and tertiary arrangement of helices 1–3 are
conserved, sequence diversity leads to differences in s4
interactions. The M. tuberculosis sD4 and the s
D
4/RsdA
structures reveal a new variant that the tertiary conform-
ation is more conserved than the helical content in the
ASD. A structural Zn2+ has also been suggested to
maintain the tertiary conformation of an ASD leading
to a mechanistic hypothesis that the release of the bound
Zn2+ cofactor in oxidative conditions regulates s/anti-s
factor interactions. This mechanism is different from a
proteolysis mechanism first proposed in the case of
E. coli RseA. In this case, selective exposure of sequence
motifs precede a proteolytic cascade that eventually leads
to the degradation of an anti-s factor. In both these
Table 1. Data, phasing and refinement statistics
Crystal sD4 s
D
4/RsdA
PDB ID 3VFZ 3VEP
Wavelength (A˚) 0.978 0.978
Resolution (A˚)a 33.88–1.90 (2.0–1.9) 49.87–2.5 (2.64–2.50)
Unit cell parameters (A˚) a=80.43, b=35.70, c=50.92 a=99.74, b=110.72, c=73.13
b=122.59 b=133
Space group C121 C121
Total number of reflectionsa 69 206 (10 166) 139 525 (22 123)
Number of unique reflectionsa 9711 (1422) 18 114 (2855)
Completeness (%)a 99.6 (99.6) 98.3 (97.9)
Multiplicitya 7.1 (7.1) 7.7 (7.7)
Rmerge (%)
a,b 6.2 (58.8) 6.8 (44.2)
<I>/s(I)a 17.9 (3.4) 15.6 (4.4)
II. Phasing
Selenium (SAD) Selenium (MR-SAD)
Figure of merit 0.38 0.36
III. Refinement statistics
Rcryst (%)/Rfree (%)
c 19.8/23.8 24.3/28.7
RMSbond (A˚) 0.006 0.015
RMSangle (degree) 0.900 1.832
B factor (A˚2)d 46.96 53.62
aValues in parentheses are for the highest-resolution shell.
bRmerge=
P P
I jI(h)j, where I(h) is the mean intensity after rejections.
cRcryst=
P j Fp-Fcj / P jFpj; Rfree, the same as Rcryst but calculated on 5% of data excluded from refinement.
dAveraged over all atoms.
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mechanisms, conformational changes induced either tem-
porally by environmental conditions or irreversibly due to
proteolysis lead to the release of a free, active s-factor.
However, the sequence-structure determinants that dictate
the choice of a regulatory mechanism remained unclear.
A comparison between the sL4/RslA and the s
D
4/RsdA
complexes provided an opportunity to examine these dif-
ferent regulatory mechanisms.
Conformational dynamics of the ASD
MD simulations were performed on the canonical ASD of
E. coli RseA as well as the ASDs in M. tuberculosis RslA
and RsdA. These simulations were performed to examine
if the differences between the crystal structures of the
ASDs in RsdA and RslA were functionally significant,
i.e. the conformational features of these ASDs dictated
the regulatory mechanisms adopted by these proteins. In
all cases, the simulations stabilized within 10 ns (Supple-
mentary Figure S2a and b). Clustering of the conformers
was based on the a-carbon r.m.s.d. of simulated confor-
mers at different time-points with respect to the crystal
structure (39). The normalized population distribution
obtained for the RsdA model in the free form (simulations
on the RsdA model alone) and the bound form (simula-
tions on the sD4/RsdA complex) resulted in two major
peaks in the bound form and three distinct conformational
Figure 1. Structure of sD4/RsdA complex. (a) In this representation, the C
a backbone of RsdA (green) is shown on the surface of sD4 (wheat). The
residues at the interface of sD4 that interact with RsdA are highlighted. These interacting residues (based on a cut-off criterion of 4 A˚) reveal that the
sD4/RsdA interface is substantially hydrophobic in nature. (b) Helix H2 of RslA is not involved in s
L
4/RslA interactions. The C
a backbone trace of
RslA (sand color) on the surface of sL4 (blue) also shows the location of the Zn
2+ cofactor vis-a`-vis the sL4/RslA interface. The residues at the s
L
4/
RslA interface are highlighted (16). (c) Sequence alignment of RsdA homologs reveals conserved residues that are buried at the sD4/RsdA interface
(gray background). The secondary structure annotations are based on the M. tuberculosis RsdA structure. (d) The ASDs of M. tuberculosis RsdA
(green), M. tuberculosis RslA (sand) (16), R. sphaeroides ChrR (pink) (31) and E. coli RseA (orange) (32) are superposed over the first three a helices
(H1–H3). (e) Time evolution of secondary structural elements in RsdA during the course of MD simulations. DSSP annotation was used to
determine the secondary structural information. In this representation, the helical conformation is shown in blue, turn in yellow, bend in green
and coil in white. The time-evolution profile reveals that the polypeptide stretch corresponding to H2 of the classical ASD fold remains disordered
during the course of the MD simulations. (f) The secondary structural contents do not substantially vary in the time course of MD simulations on
RslA. The secondary structure annotations are same as panel e.
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ensembles in the free form (Figure 2a). A superposition of
the conformers illustrates the differences between free and
bound forms of RsdA (Figure 2b). A comparison between
these conformational ensembles revealed a change in the
conformation of RsdA (r.m.s.d. of 5 A˚ over a-carbons)
between the free and anti-s–bound states. Helices H1
and H3 of RsdA undergo conformational changes
accompanied by a helix to loop transition of helix H1.
RsdA lacks helix H2. The simulations suggest that the
loop in RsdA does not adopt an a helical conformation.
Furthermore, no secondary structural transitions in H2
in either RseA or RslA were seen (Figure 1e and f). The re-
sults of these simulations are consistent with far ultraviolet
circular dichroism (CD) spectra on these protein samples
(Supplementary Figure S3). In these spectroscopic studies,
a-helicity was induced by the addition of trifluoroethanol
(40). The larger increase in the a-helical content of RsdA
in the free form is consistent with the observation made on
the basis of the crystal structure and MD simulations.
The difference in the radius of gyration of RsdA
between the free form and the sD4/RsdA complex
suggest that RsdA in the free form is more compact
Figure 2. Conformational ensembles of the ASDs in RsdA and RslA. (a) MD simulations suggest that M. tuberculosis RsdA adopts different
conformations in the sD4/RsdA complex (red; peaks 1 and 2) and free form (black; peaks 3, 4 and 5). The r.m.s.d. values were determined with
respect to the initial model (crystal structure) (b) Superposition of a-carbon atoms of representative structures from each peak. Structures corres-
ponding to peak 1 (cyan), peak 2 (brown), peak 3 (red), peak 4 (orange) and peak 5 (pink) are shown. (c) Population distribution of RslA in the
sL4/RslA complex (red, peak 1) and the free form (black, peak 2). The r.m.s.d. are with respect to the crystal structure. (d) Superposition of the C
a
traces corresponding to representative structures from each conformational ensemble. Structures representing peak 1 (red) and peak 2 (cyan) are
shown. (e) The conformational ensembles derived from MD simulations on sD4 in the s
D
4/RsdA complex (red; peak 1) and the free form (black;
peak 2). (f) A superposition of the Ca traces corresponding to representative structures from peak 1 (red) and peak 2 (yellow) reveal minor
conformational changes.
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when compared with the bound form. This holds true even
in the case of RslA (Supplementary Figure S2c).
Simulations with the RslA structure and the sL4/RslA
complex suggested two prominent conformational ensem-
bles—one associated with the free state, and one for the
complex (Figure 2c). In this case, a structural superpos-
ition of the two conformers suggests that helix H3 of RslA
changes conformation between free and the sL4 bound
states (Figure 2d). In this context, we note that no con-
formational changes were seen either between the crystal
structures of free sD4 or s
D
4 in the s
D
4/RsdA complex or
the sD4 conformation obtained from MD simulations
(Figure 2e and f). Put together, these simulations suggest
that conformational changes are localized to the ASD on
binding the cognate s factor.
Interactions between the ASD of RsdA and pD4
The binding affinity of the RsdA ASD to sD4 and full-
length sD was determined by SPR experiments. Analysis
of SPR sensograms suggest a dissociation constant (Kd)
of ca 10 mM and 2 mM for sD4 and full-length s
D, respect-
ively (Figure 3a and b) (Table 2). The binding affinity is
less than that reported for the sL/RslA complex (20 nM)
or the sE/RseA complex (10 pM) (8,16). We note that the
buried surface area in the sL4/RslA, s
E
4/RseA and
the sD4/RsdA complexes are broadly similar (Supplemen-
tary Table S2). The differences in the binding affinity are
thus likely due to differences in the sequence composition
or the flexibility of the ASD. An observation from the
multiple sequence alignment suggested Trp50 to be well
conserved across RsdA homologs (Figure 1c). Addi-
tionally, MD simulations suggested Trp50 to be important
in sD4/RsdA interactions (Figure 3d). This observation
was validated experimentally using a W50A mutant of
RsdA. The W50A mutant showed a 10-fold reduction in
binding affinity when compared with wild type RsdA
(Figure 3c). MD simulations of the sL4/RslA and the
sD4/RsdA complexes also reveal differences in the
protein–protein interaction interface. A network of inter-
face residues was identified based on their interactions
during MD simulations of the sD4/RsdA and s
L
4/RslA
complexes. Interface residues in the sD4/RsdA complex
were Leu24, Leu43, Leu46, Leu47 and Trp50. These
residues make the most number of contacts with sD4
during the course of simulation. Similarly, conserved
Figure 3. SPR sensograms for the interaction of sD with RsdA. (a) SPR measurements of sD/RsdA interactions reveal that the binding affinity of
full-length sD (containing both sD2 and s
D
4 domains) with RsdA is ca 2.0 mM. (b) Interaction of s
D
4 with RsdA reveals a 4-fold reduction in the
binding affinity when compared with full-length sD. (c) The conserved tryptophan residue in RsdA (W50) contributes substantially to sD/RsdA
interactions. The RsdA1–94W50A point mutant interacts with sD with a 10-fold reduction in the binding affinity (corresponding to a Kd of 20mM).
(d) MD simulations support the role of Trp50 in sD/RsdA interactions. A superposition of structures obtained during the course of MD simulations
reveal that interactions between Trp50 of RsdA and residues of sD4 (Val148, Met151, Leu155, Ile167, Val170 and Val171) are conserved during the
course of MD simulations. In this representation, the a-carbon trace is shown in gray.
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residues at the sL4/RslA interface are Leu71, Leu74,
Val67, Gln73 and Ala38. These residues are shown in
the interaction network of sD4/RsdA and the s
L
4/RslA
complexes (Supplementary Figure S4). An analysis of
these interaction networks also suggests that the
s/anti-s interface is largely hydrophobic. This obser-
vation is similar to that seen in the sE/RseA or the
sE/ChrR s/anti-s complex.
RsdA is selectively degraded by the ClpX–ClpP
proteasomal complex
Activation of the ECF s factor sE by the selective prote-
olysis of the anti-s factor RseA is well characterized in
E. coli. DegS, a site-1 protease, and RseP, a site-2
protease, cleave RseA into periplasmic and intramembrane
regions. The ASD of RseA is released into the cytosol with
a ‘VAA’ sequence motif at the C-terminus (41). This is then
selectively proteolyzed by Clp proteases (8). Neither site-1
nor site-2 proteases that act onM. tuberculosis RsdA have
been identified thus far. However, sequence analysis
revealed a similar sequence motif (VAA) to that of
E. coli RseA (this motif is AAA in RslA) in the trans-
membrane region (Supplementary Figure S5). M. tubercu-
losis and E. coli ClpX and ClpP proteases share >50%
sequence identity and the active site residues are well
conserved (42). M. tuberculosis has two ClpP proteins,
ClpP1 and ClpP2. A mixed ClpP1–ClpP2 complex was
shown to be active against small peptides and proteins
on binding N-blocked dipeptide activators (14).
Experiments with freshly purified M. tuberculosis ClpX,
ClpP1 and ClpP2 revealed that RsdA194, both in the
free form and in complex with sD, is proteolyzed specific-
ally by the ClpX–ClpP1–ClpP2 proteasomal complex. We
note that while the ClpX–ClpP1 proteasomal complex is
inactive, proteolytic activity of ClpX–ClpP2 is substan-
tially enhanced by the addition of ClpP1 (Figure 4a).
This observation is similar to that of the anti-s factor
M. tuberculosis RseA, where the ClpC1–ClpP2 complex
was able to cleave RseA specifically in a phosphoryl-
ation-dependent manner, whereas the ClpC1–ClpP1
assembly could not (43). These observations are consistent
with the crystal structure of M. tuberculosis ClpP1 that
revealed a smaller pore size compared with other ClpP
Figure 4. Activation of sD by the selective proteolysis of RsdA. (a and b) The ClpX–ClpP1–ClpP2 proteasomal assembly degrades RsdA, whereas
RslA is resistant to proteolysis in vitro. These proteolysis experiments reveal that the proteolytic assembly is most efficient in the case of a ternary
complex that contains ClpX, ClpP1 and ClpP2. Samples were obtained at specific time intervals. Immunoblots were performed using anti-histidine
monoclonal antibodies (for RsdA and RslA), whereas sD and sL were detected by antibodies raised against purified recombinant sD and sL. The
relative influence of the sequence motifs was examined by mutational analysis (VAA to VDD in RsdA; AAA to VAA in RslA). These are shown in
lane 3 of the immunoblots. (c) A quantitative representation of the data shown in panels (a and b). Each data point corresponding to the fraction of
protein retained after proteolysis represents an average of three experiments. (d and e) The ClpX–ClpP1–ClpP2 assembly does not affect the sL/RslA
complex. Mutation of the recognition motif AAA to VAA does not convert RslA into a proteolytically labile ASD. These results are quantified in
panel (e).
Table 2. Comparison of the binding affinity of characterized s/anti-s
complexes
Construct Dissociation constant (Kd)
sD/RsdA1–94 2.6±1.8 mM
sD4/RsdA
1–94 10.3±3.5 mM
sD/RsdA1–94W50A 20.1±4.2 mM
sL/RslA1–108a 20.0 nM
sE/RseA1–90b 10.0 pM
aDissociation constants for M. tuberculosis sL/RslA obtained from (16).
bData for E. coli sE/RseA noted from (8).
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assemblies potentially making this protease subunit
inactive (13,44,45). The proteolytic mechanism that
governs the dissociation of the M. tuberculosis sD/RsdA
complex is thus similar to the E. coli sE/RseA system. It
was also demonstrated that the E. coli RseA1108 VDD
mutant was resistant to proteolysis by Clp proteases
(41,46). The VAA motif at the C-terminus of RsdA194
was mutated to VDD. A truncated version of the RsdA
ASD that lacks the ‘VAA’ sequence motif was also
examined (data not shown). The VDD as well as the
truncated mutants of RsdA were resistant to proteolysis
by the ClpX–ClpP1–ClpP2 complex (Figure 4a).
Surprisingly, RslA1125AAA both in the free state as well
as in complex with sL was resistant to degradation either
by the ClpX–ClpP1 or ClpX–ClpP2 or the ClpX–ClpP1–
ClpP2 protease assemblies, either in the apo (Zn2+-free)
form or the holo (Zn2+-bound) forms (Figure 4e).
Addition of the sequence motif to RslA (mutating the
AAA motif to VAA) did not appear to induce proteolytic
susceptibility in RslA. This finding suggests that other
sequence and/or conformational features apart from the
VAA sequence motif determine the proteolytic degrad-
ation of an ASD. While adaptor proteins are known to
increase the proteolytic efficiency of ClpX–ClpP proteases
in E. coli and B. subtilis (47), we could not identify a hom-
ologous adaptor protein in M. tuberculosis. These results
suggest that sD is activated by the specific proteolysis of
the anti-s factor RsdA, while sL is activated by the release
of Zn2+from RslA on oxidative stress. In a related finding,
M. tuberculosis RslA was shown to be a substrate for Rip1,
a restricted intramembrane protease. M. tuberculosis
RsdA, on the other hand, is resistant to proteolysis by
M. tuberculosis Rip1 (15). This suggests multiple proteo-
lytic cascades dictate the release of specific s factors.
Multiple mechanisms for the release of a s factor from a
s/anti-s complex provide an additional strategy to address
specific environmental niches. Thus while in one case, the
anti-s factor is proteolytically cleaved by Clp proteases (in
the case of RsdA), in the other ASD (RslA) the anti-s
factor is released from its cognate s factor due to conform-
ational rearrangements on signal recognition (Figure 5).
Put together, the ASD demonstrates surprisingly diverse
regulatory mechanisms embedded in a simple four-helical
structural scaffold. While structural conservation is essen-
tial for binding a cognate s factor, incorporation of differ-
ent, perhaps multiple, regulatory mechanisms in an ASD
provides a route to achieve temporal changes in s-factor
levels corresponding to diverse environmental stimuli.
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